Table of Contents
SGLT2 inhibitors are a class of medications commonly prescribed for type 2 diabetes management. They work by blocking the sodium-glucose co-transporter 2 in the kidneys, leading to increased glucose excretion in urine. While effective, these drugs have been associated with a rare but serious side effect: ketoacidosis.
Understanding Ketoacidosis and SGLT2 Inhibitors
Ketoacidosis occurs when the body produces high levels of ketones, acids that can build up in the blood and cause dangerous complications. Traditionally, ketoacidosis is linked with type 1 diabetes, but cases have been reported in patients taking SGLT2 inhibitors even if they have type 2 diabetes.
Signs and Symptoms to Recognize
- Abdominal pain
- Nausea or vomiting
- Shortness of breath
- Confusion or difficulty concentrating
- Fruity-scented breath
- Rapid breathing
Pharmacy staff should be vigilant for these symptoms, especially in patients who have recently started SGLT2 inhibitors or have other risk factors for ketoacidosis.
Risk Factors and Prevention
Several factors can increase the risk of ketoacidosis in patients taking SGLT2 inhibitors:
- Dehydration or low fluid intake
- Severe illness or infection
- Reduced insulin doses
- Alcohol consumption
- Low carbohydrate diet
Preventative measures include patient education on recognizing early symptoms, advising adequate hydration, and ensuring proper medication adherence. Patients should be counseled to seek medical attention if symptoms develop.
What Pharmacy Staff Should Do
Pharmacy staff play a crucial role in patient safety by:
- Providing counseling on potential side effects
- Educating patients on symptom recognition
- Encouraging patients to maintain hydration
- Monitoring for drug interactions or contraindications
- Reporting adverse events to healthcare providers
Staying informed about the latest guidelines and evidence regarding SGLT2 inhibitors and ketoacidosis is essential for optimal patient care and safety.